These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. An unusual recurrence of antitubercular drug induced hepatotoxicity in a child. Bhatia S; Tullu MS; Kannan S; Gogtay NJ; Thatte UM; Lahiri KR J Postgrad Med; 2011; 57(2):147-52. PubMed ID: 21654145 [No Abstract] [Full Text] [Related]
48. [Alopecia areata in a patient treated with antitubercular drugs]. Tella E; Daubercies G; Sin C; Marchal A; Sigal ML; Mahé E Ann Dermatol Venereol; 2014 Apr; 141(4):295-7. PubMed ID: 24703645 [No Abstract] [Full Text] [Related]
49. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report]. Costin M; Tesloianu A; Mihăescu T; Butnaru E Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942 [TBL] [Abstract][Full Text] [Related]
50. Adverse effects of antituberculosis drugs. Girling DJ Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920 [No Abstract] [Full Text] [Related]
51. [Rifapex, a new antituberculosis agent]. Sokolova GB; Krasnov VA; Reĭkhrud TA; Tsybanev AA Antibiot Khimioter; 2009; 54(1-2):38-41. PubMed ID: 19499716 [TBL] [Abstract][Full Text] [Related]
52. Any questions? How should a patient be managed who is being treated for sputum positive pulmonary tuberculosis and becomes jaundiced in the third week of chemotherapy? Campbell IA Tubercle; 1990 Jun; 71(2):149. PubMed ID: 2219468 [No Abstract] [Full Text] [Related]
53. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
54. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
55. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Ena J; Valls V Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411 [TBL] [Abstract][Full Text] [Related]
56. Letter: Rifampin in initial treatment of pulmonary tuberculosis: a U.S. Public Health Service tuberculosis therapy trial. Israel HL Am Rev Respir Dis; 1974 Jul; 110(1):104. PubMed ID: 4834622 [No Abstract] [Full Text] [Related]
57. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Eule H; Werner E; Winsel K; Iwainsky H Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295 [No Abstract] [Full Text] [Related]
58. [Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents]. Firsova VA; Nadyrshina RSh; Melikova VM Probl Tuberk; 1986; (5):14-7. PubMed ID: 3737587 [No Abstract] [Full Text] [Related]
59. Pulmonary tuberculosis initial treatment. N Z Med J; 1978 May; 87(611):321-2. PubMed ID: 276705 [No Abstract] [Full Text] [Related]
60. A man with a blistering eruption and tuberculosis. Lee CH; Yuen MM; Chow WS; Tso AW; Yeung CK; Chan JC; Chau CH; Lam KS BMJ; 2012 Jan; 344():d8351. PubMed ID: 22228698 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]